Organ-preserving treatment in inoperable patients with primary oral and oropharyngeal carcinoma. Chances and limitations;Organerhaltende Therapie bei inoperablen Patienten mit primären Mundhöhlenund Oropharynxkarzinomen. Möglichkeiten und Grenzen

Mund - Kiefer - und Gesichtschirurgie

Volumn 10, Issue 3, 2006, Pages 168-177

  Kovacs A F ^a   Eberlein, K ^a   Smolarz, A ^a   Weidauer, S ^a   Rohde, S ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

High dose chemotherapy; Nonoperative therapy; Radiochemotherapy; Radiotherapy; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; TAXOID;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PALLIATIVE THERAPY; PATHOLOGY; RETREATMENT; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PALLIATIVE CARE; RADIOTHERAPY, ADJUVANT; RETREATMENT; SURVIVAL RATE; TAXOIDS;

EID: 33646385636     PISSN: 14329417     EISSN: 14343940     Source Type: Journal    
DOI: 10.1007/s10006-006-0684-2     Document Type: Article

References (21)

1. Bernier J, Domenge C, Ozsahin M et al. for the European Organization for Research and Treatment of Cancer Trial 22931 (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945-1952
2. Bernier J, Cooper JS, Pajak TF et al. (2005) Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27: 843-850
3. Calais G, Bardet E, Sire C et al. (2004) Radiotherapy with concomitant weekly docetaxel for stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial. Int J Radiat Oncol Biol Phys 58: 161-166
4. Cooper JS, Pajak TF, Forastière AA et al. for the Radiation Therapy Oncology Group 9501/Intergroup (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350: 1937-1944
5. Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685-1690
6. Forastière A.A. Goepfert H. Maor M. et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349; 2091-2098
7. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
8. Kovács AF (2006) Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients - final results of a pilot study composed with treatment-dependent prognosis index. J Craniomaxillofac Surg 34: 74-84
9. Kovács AF, Mose S (2005) Postoperative radiation and concurrent chemotherapy (RCT) with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer - long-term results. J Clin Oncol 23 (Suppl): 511
10. Kovács AF, Acker P, Berner U, Risse JH (2001) Sentinel-Lymphknoten-Exstirpation. Behandlungsmethode des N0-Halses bei Patienten mit oralen und oropharyngealen Karzinomen. HNO 49: 646-653
11. Kovács AF, Schiemann M, Turowski B (2002) Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study. J Craniomaxillofac Surg 30: 112-120
12. Kovács AF, Landes CA, Hamscho N et al. (2005) Pattern of drainage in sentinel lymph nodes after intra-arterial chemotherapy for oral and oropharyngeal cancer. J Oral Maxillofac Surg 63: 185-190
13. Kovács AF, Landes CA, Hamscho N et al. (2005) Sentinel node biopsy as staging tool in a multimodality treatment approach to cancer of the oral cavity and the oropharynx. Otolaryngol Head Neck Surg 132: 570-576
14. Kovács AF, Walendzik H, Döbert N, Menzel C (2005) Sentinel-Lymphonodektomie als Stagingmethode bei Mundhöhlen- und Oropharynxkarzinomen - Analyse von 70 Patienten. HNO 53: 531-538
15. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
16. Oken MM, Creech RH, Tormey DC et al. (1982) Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655
17. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355: 949-955
18. Robbins KT, Kumar P, Wong FSet al. (2000) Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients. Head Neck 22: 687-693
19. Sinikovic B, Hofele C, Karstens JA, Eckardt A (2005) Preoperative radiochemotherapy of stage III and IV squamous cell carcinoma of the oral cavity: Completed phase II study with a 6 year follow-up. Int J Oral Maxillofac Surg 34 (Suppl 1): 27
20. Sobin LH, Wittekind C (eds) (1997) UICC: TNM classification of malignant tumours. Wiley & Sons, New York
21. Wendt TG, Grabenbauer GG, Rodel CM et al. (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16: 1318-1324